Mercado cerrado -
Otros sitios de cotización
|
Varia. Cinco días. | Varia. 1 de enero. | ||
0,7272 USD | +10,18 % | +10,48 % | +113,76 % |
Resumen de negocios
Número de empleados: 10
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
Founder | 40 | 01/12/14 | |
Kim Tsuchimoto
DFI | Director of Finance/CFO | 61 | 01/06/15 |
Laura Kelly
CTO | Chief Tech/Sci/R&D Officer | - | 18/02/21 |
Andrew Cittadine
COO | Chief Operating Officer | 52 | 01/06/21 |
Patrice Rioux
CTO | Chief Tech/Sci/R&D Officer | 73 | 01/12/16 |
Administradores
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Michael Brown
BRD | Director/Board Member | 67 | 01/12/14 |
Arthur Klausner
BRD | Director/Board Member | 64 | 01/08/17 |
Kim Tsuchimoto
DFI | Director of Finance/CFO | 61 | 01/06/15 |
Founder | 71 | 01/12/14 | |
Raymond Anderson
BRD | Director/Board Member | 82 | 01/04/17 |
Founder | 40 | 01/12/14 |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 1 | 17 454 925 | 8 316 964 ( 47,65 %) | 0 | 47,65 % |
Información de la empresa
Monopar Therapeutics, Inc.
1000 Skokie Boulevard Suite 350
60091, Wilmette
+847 388 0349
http://www.monopartx.comSector
Revisiones del BPA
Varia. 1 de ene. | Capi. | |
---|---|---|
+113,76 % | 12,69 M | |
+25,69 % | 47,86 mil M | |
+46,90 % | 41,42 mil M | |
-3,46 % | 40,66 mil M | |
-6,20 % | 28,92 mil M | |
+9,17 % | 25,55 mil M | |
-20,42 % | 19,27 mil M | |
+0,17 % | 12,15 mil M | |
+28,07 % | 12,14 mil M | |
-1,24 % | 11,99 mil M |
- Bolsa de valores
- Acciones
- Acción MNPR
- Empresa Monopar Therapeutics Inc.